ABUS
Arbutus Biopharma Corp
Price:  
3.15 
USD
Volume:  
743,816.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Arbutus Stock Forecast & Price Target

Arbutus Stock Price Forecast

The average stock forecast for Arbutus Biopharma Corp (ABUS) in the next 12 months is 5.36 USD. This price target corresponds to an upside of 71.63%. The range of stock forecasts for Arbutus is 4.04 - 7.35 USD. Based on the ratings of 11 analysts, the consensus recommendation for Arbutus is BUY.
Target Low Average Median High
Price (USD) 4.04 5.36 5.10 7.35
Upside 29.49% 71.63% 63.46% 135.58%

Recommendation Trends

The latest consensus rating for Arbutus is "BUY". This is the average recommendation of 11 analysts: 0 strong sell, 0 sell, 2 hold, 6 buy, 3 strong buy. In the previous period, 10 analysts also majorly recommmended "BUY" for Arbutus.

Arbutus Financial Stock Forecast

Revenue This Year
6.41M
3.89%
from 6.17M
Revenue Next Year
8.19M
27.75%
from 6.41M
EPS This Year
-0.33
-9.44%
from -0.37
EPS Next Year
-0.41
25.23%
from -0.33